Hawthorn Proanthocyanidins Induce the Apoptosis of Huh-7 Cells by Down-Regulating the Traf6/NF-κB Signaling Pathway

被引：0
|
作者：
Mi W. [1 ]
Yin S. [1 ]
Gao L. [2 ]
Li N. [1 ]
Shi T. [1 ]
机构：
[1] School of Public Health and Management, Binzhou Medical University, Yantai
[2] Oncology Department, Binzhou Medical University Hospital, Binzhou
来源：
Shipin Kexue/Food Science | 2023年 / 44卷 / 05期
关键词：
cell apoptosis; hawthorn proanthocyanidin; hepatocellular carcioma; nuclear factor kappa B; tumor necrosis factor receptor associated factor 6;
D O I：
10.7506/spkx1002-6630-20220309-105
中图分类号：
学科分类号：
摘要：
The purpose of this study was to explore the mechanism by which hawthorn proanthocyanidins (HPC) inhibit cell proliferation and promote apoptosis in Huh-7 cells. Huh-7 cells and Traf6-overexpressed Huh-7 cells were cultured routinely at HPC concentrations of 0, 5, 10, 20, 40 and 80 μg/mL. Cell counting kit-8 (CCK-8) was used to detect the inhibitory effect of HPC on the proliferation of Huh-7 cells and Traf6-overexpressed Huh-7 cells. The mRNA expression of the tumor necrosis factor receptor associated factor 6 (Traf6), nuclear factor kappa-B p65 (NF-κB p65), Bax and caspase-3 genes were evaluated by real-time polymerase chain reaction (PCR). The protein expression of Traf6, NF-κB p65, Bax and caspase-3 were tested by Western blotting. Double staining with Annexin V-FITC and propidium iodide (PI) was used to test and calculate the apoptosis of Huh-7 cells. Treatment with HPC at concentrations higher than 20 μg/mL could inhibit Huh-7 cell proliferation in a dose-dependent way (P < 0.05). The over-expression of Traf6 promoted the proliferation of Huh-7 cells．Compared with the control group, HPC at 40 μg/mL significantly decreased the relative mRNA and protein expression of Traf6 and NF-κB p65 (P < 0.05), increased the relative mRNA and protein expression of Bax and caspase-3 (P < 0.05), and promoted Huh-7 cell apoptosis (P < 0.05). We concluded that HPC induce apoptosis in Huh-7 cells by down-regulating the Traf6/NF-κB signaling pathway. © 2023 Chinese Chamber of Commerce. All rights reserved.
引用
收藏
页码：96 / 102
页数：6
相关论文
共 41 条
  • [1] XU F, ZHA G, WU Y, Et al., Overexpressing incRNA SNHG16 inhibited HCC proliferation and chemoresistance by functionally sponging hsa-miR-93, Onco Targets and Therapy, 11, 7, pp. 8855-8863, (2018)
  • [2] YILMA M, SAXENA V, MEHTA N., Models to predict development or recurence of hepatocellular carcinoma (HCC) in patients with advanced hepatic fibrosis, Current Gastroenterology Reports, 24, 1, pp. 1-9, (2022)
  • [3] WANG J, HE H, JIANG Q, Et al., CBX6 promotes HCC metastasis via transcription factors snail/zeb1-mediated EMT mechanism, Onco Targets and Therapy, 13, 4, pp. 12489-12500, (2020)
  • [4] XU F, NA L, LI Y, Et al., Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours, Cell & Bioscience, 10, 1, pp. 54-56, (2020)
  • [5] SHORNING B Y, DASS M S, SMALLEY M J, Et al., The PI3K-AKTmTOR pathway and prostate cancer: at the crossroads of AR, MAPK, and WNT signaling, International Journal of Molecular Sciences, 21, 12, pp. 4507-4512, (2020)
  • [6] BERTACCHINI J, HEIDARI N, MEDIANI L, Et al., Targeting PI3K/ AKT/mTOR network for treatment of leukemia, Cellular and Molecular Life Sciences, 72, 12, pp. 2337-2347, (2015)
  • [7] SONG L, CHEN X, MI L, Et al., Icariin-induced inhibition of SIRT6/ NF-κB triggers redox mediated apoptosis and enhances anti-tumor immunity in triple-negative breast cancer, Cancer Science, 111, 11, pp. 4242-4256, (2020)
  • [8] JIANG C, SUN Z M, HU J N, Et al., Cyanidin ameliorates the progression of osteoarthritis via the Sirt6/NF-κB axis in vitro and in vivo, Food & Function, 10, 9, pp. 5873-5885, (2019)
  • [9] GUO Y J, PAN W W, LIU S B, Et al., ERK/MAPK signalling pathway and tumorigenesis, Experimental and Therapeutic Medicine, 19, 3, pp. 1997-2007, (2020)
  • [10] SABBAH D A, HAJJO R, SWEIDAN K., Review on epidermal growth factor receptor (EGFR) structure, signaling pathways, interactions, and recent updates of EGFR inhibitors, Current Topics in Medicinal Chemistry, 20, 10, pp. 815-834, (2020)
12345